Biomarkers and Respiratory Omics in Children: Predicting Disease Course
Official title: Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation - a Multi-cohort, Multi-center Study
Run by Medical University of Warsaw · NCT07232550 · Data updated 2026-11-12
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 17 Years |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw) |
| Status | Recruiting |
| Started | March 6, 2026 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT07232550 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 0-17 with indications for bronchoscopy, including asthma, protracted bacterial bronchitis, chronic cough, or other airway concerns.
✕Probably not a fit
Children without the targeted respiratory conditions or without indications for bronchoscopy may not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational cohort study will analyze bronchoalveolar lavage, mucosal biopsies, and blood samples to explore microbiome, cellular makeup, and metabolomic profiles in children with asthma, protracted bacterial bronchitis, or chronic cough. Participants undergo fiberoptic bronchoscopy during clinically indicated procedures, with follow-up over five years including non-invasive assessments and repeated respiratory tests. The goal is to identify phenotypes and risk factors that may inform treatment decisions and disease progression. Enrollment targets 160 participants across the Medical University of Warsaw and Medical University of Lodz, with data linkage to clinical history and treatment patterns.
Why it matters
Potential benefit: If successful, the study could improve how clinicians predict which children are at higher risk of worsening disease and tailor therapies accordingly.
How similar studies have gone: Previous respiratory-omics studies in adults and pediatric cohorts have shown meaningful associations between biomarkers and disease phenotypes, supporting the potential value of this approach in children.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age at the beginning of the study 0-17 years old * Clinical indication and qualification by the attending physician for fiberoptic bronchoscopy under general anesthesia: * Obstruction of the airways: * Suspicion of foreign body aspiration * Persistent stridor * Abnormal result of functional tests of respiratory system - flattening of inspiratory or expiratory curve, presence of restriction (tested vital capacity \<5 percentile) or irreversible obstruction (persistence of Tiffneau index \<5 percentile despite administration of bronchodilators) * Radiological findings located in the course of the larynx, trachea or bronchi * Persistent atelectasis on subsequent radiological examinations * Persistent cough \>4 weeks * Hemoptysis * Suspected laryngomalacia or tracheobronchomalacia * Suspected tracheoesophageal fistula * Persistent dyspnea unresponsive to anti-asthmatic treatment used for min. 2 months, with no other identifiable causes * Radiologically detected mediastinal abnormalities * Suspected presence of a vascular ring * Presence of excessive secretions that are impossible for the patient to expectorate * Fine needle biopsy of cystic lesions * Obtained consent from patient/legal guardian for participation in the study Exclusion Criteria: * Active acute respiratory infection up to 4 weeks before the procedure * Taking antibiotics or systemic glucocorticosteroids up to 4 weeks before the procedure * Patients with very severe comorbidities (congenital immunodeficiencies, genetic disorders, neurological or neuromuscular diseases, cancer, severe congenital heart defects, heart failure, liver failure, inflammatory bowel disease, celiac disease) * Patients with blood clotting disorders * Children with diagnosed respiratory diseases other than asthma and protracted bacterial bronchitis - including interstitial diseases, tuberculosis, inflammation of small and medium-sized blood vessels * Patients for whom \>48 hours have passed between suspicion of foreign body aspiration and interventional bronchoscopy * Children with foreign body aspiration having a foreign body located in the trachea
Where it's running
-
Żwirki i Wigury 63A
Warsaw, Poland Recruiting
Study contacts
- Principal investigator: Wojciech Feleszko, MD, PhD — Medical University of Warsaw
- Study coordinator: Tomasz Kopiec, MD
- Email: tomasz.kopiec@wum.edu.pl
- Phone: +48505300599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
N-WATCH: Can a simple breath device help monitor asthma in kids
This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
Chronic Cough and Airway Remodelling in Refractory Cough Patients
This study tests whether long-lasting chronic cough damages and remodels the airways in adults who have had cough for over a year and have not responded to prior treatments.
-
Treatments for prolonged cough in children
It tests whether an inhaled steroid helps children with dry prolonged cough and whether an antibiotic helps children with wet prolonged cough compared with placebo.
-
Brief, breath-focused ACT for adults with chronic cough
This pilot test checks if a short, breath-control-oriented Acceptance and Commitment Therapy program is doable, acceptable, and safe for adults who have chronic cough.
-
Lung MRI for children with protracted bacterial bronchitis (PBB)
We will try using MRI to look at the lungs of children aged 5–17 with suspected PBB so they might avoid anaesthesia and radiation from bronchoscopy and CT.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.